Debaryomyces hansenii

Debaryomyces hansenii: A Comprehensive Reference

1. Identity, Nomenclature, and Natural Sources

Scientific Classification and Names

Debaryomyces hansenii, also known as Candida famata, is a species of yeast in the family Saccharomycetaceae. Its full taxonomic hierarchy places it within the kingdom Fungi, phylum Ascomycota, subphylum Saccharomycotina, class Saccharomycetes, order Saccharomycetales, and family Saccharomycetaceae (or, under some recent reclassifications, Debaryomycetaceae).

Lodder and Kreger-van Rij (1952) proposed to retain the name Debaryomyces as a nomen conservandum and indicated Debaryomyces hansenii (Zopf) Lodder & Kreger-van Rij as the type species of the genus. The anamorph name of D. hansenii is Candida famata. Synonyms of this species include Debaryozyma hansenii, Pichia hansenii, Torulaspora hansenii, and Debaryomyces hansenii var. hansenii, among others.

The species comprises two varieties: D. hansenii var. hansenii and var. fabryii. These two groups can be differentiated via rRNA, the electrophoretic mobility of their glucose-6-phosphate dehydrogenase, or by their maximum growth temperatures (35 °C for var. hansenii and 39 °C for var. fabryii).

Natural Habitats and Sources

The yeast Debaryomyces hansenii, which has been isolated from saline environments such as seawater, concentrated brines, and salty food, is one of the most halotolerant yeast species. It can grow in media containing as high as 4 M NaCl, while the growth of Saccharomyces cerevisiae is limited in media with more than 1.7 M NaCl.

Debaryomyces hansenii is a halotolerant/halophilic yeast that can be found in very different environments such as salty water, food, or mammals. Strains classified as Debaryomyces hansenii are halotolerant yeasts, isolated from sources as diverse as man, salted foods, cheese, and soil.

It is a common species in all types of cheese, including soft cheeses and the brines of semi-hard and hard cheeses, and the most common yeast among 383 isolates from samples of unsulfited or sulfited sausages, skinless sausages, and minced beef.

Debaryomyces hansenii is a yeast that belongs to the natural microbiota of carnivorous fish, and offers different benefits in terms of health and performance.

Common Preparations and Forms

As a functional ingredient, D. hansenii is encountered in multiple forms depending on the intended application:

• Live whole yeast cells: Studies have explored the effects of supplementation levels of Debaryomyces hansenii (at concentrations such as 1.1% and 2.2%) as a probiotic in diets.
• Hydrolyzed yeast preparations: Two hydrolyzed Debaryomyces hansenii yeast-based products (designated LAN4 and LAN6) have been examined for their physiological and immune effects in studies of Atlantic salmon.
• Extracted β-glucans: The structural characterization of yeast glucans by proton nuclear magnetic resonance has indicated structures containing (1-6)-branched (1-3)-β-D-glucan.
• Starter cultures in food fermentation: Strains of Debaryomyces hansenii are inoculated in fermented sausages and other products to study their effects as starter cultures.

As this species is included in the QPS EFSA list (Qualified Presumption of Safety — European Food Safety Authority), it is considered appealing for feed or food-related applications.

2. Traditional and Historical Use

Millennia of Inadvertent Use in Fermented Foods

Yeasts have been used for millennia due to their fermentative activity to produce highly demanded foods such as bread, cheese, wine, and beer, among others. D. hansenii specifically has been a natural, persistent, and functionally important component of the microbiota in salt-fermented and cured foods across multiple cultures, though its identity as a distinct species was not established until the 20th century.

Debaryomyces hansenii appears in the inventory of microorganisms with technological benefits for use in food fermentation. Its presence in food is doubly relevant: on the one hand, it has a positive role, metabolizing lactic acid and raising the pH, contributing to the ripening of cheeses by enabling the growth of proteolytic bacteria, or contributing to the production of certain cheeses, such as Roquefort, by forming slime on the surface.

Moreover, the assimilation of lactose, lactic acid, and its proteolytic and lipolytic activities contribute to cheese aroma. It also improves the sensory quality of fermented meat, such as sausages, salami, and Iberian dry-cured ham, because of the capacity to grow at low temperatures, halotolerance, and the use of nitrates and lactic acid.

It is found in all types of cheeses, including soft, semi-hard, and hard cheeses, where it contributes to ripening and flavor development. It is also abundant in sausages, dry-meat products, and Korean fermented soy sauce (ganjang).

Role in Traditional Meat Products

The high salt concentration and the low water activity that are typical of fermented sausages favor the growth of Debaryomyces species, mostly D. hansenii, Y. lipolytica, and various Candida species, contributing to the development of color (by removing the oxygen) and flavor (by degrading peroxides and via lipolytic and proteolytic activities). Hydrolytic and oxidative changes carried out by yeasts during ripening produce the distinctive flavors of these products.

A generally accepted idea is that the generation of volatile compounds by D. hansenii is one of the most important contributions to the ripening process in dry-meat products. It is known that D. hansenii is abundant in sausages and dry-meat products.

The inoculation of D. hansenii into low-sodium fermented sausages made from boar meat can effectively mask boar taint by generating volatile compounds with fruity and cheesy aromas. In dry-cured pork belly, inoculation with D. hansenii has also been shown to promote muscle protein degradation, enhance amino acid accumulation, and facilitate the formation of aldehydes, esters, alcohols, ketones, and organic acids.

Industrial Riboflavin Production

Debaryomyces hansenii (teleomorph of asporogenous strains known as Candida famata) belongs to the group of so-named "flavinogenic yeasts" capable of riboflavin oversynthesis during starvation for iron. Some strains of C. famata belong to the most flavinogenic organisms known (accumulating up to 20 mg of riboflavin in 1 ml of the medium) and were used for industrial production of riboflavin in the USA for a long time. Many strains of D. hansenii are characterized by high salt tolerance and are used for ageing of cheeses, whereas some others are able to convert xylose to xylitol, an anti-caries sweetener.

3. Key Constituents and Active Compounds

Cell Wall Components

Yeasts are a rich source of nutrients and protein-related compounds with a wide range of bioactive activities. Yeast cells contain different types of wall-related compounds, like glucans and polyamines (biologically active amines), which are essential for the maintenance of life. Specifically, amines have been observed to be relevant to normal cell development and are involved in several cellular processes, along with systemic benefits for animals.

The structural characterization of D. hansenii yeast glucans by proton nuclear magnetic resonance has indicated structures containing (1-6)-branched (1-3)-β-D-glucan. These branched β-glucans are a primary immunologically active cell-wall component.

Polyunsaturated Fatty Acids

This yeast has a high amount of n−3 polyunsaturated fatty acids with high concentrations of oleic and linoleic acids, which may confer nutritional and therapeutic values.

Polyols and Sugar Alcohols

The species has been demonstrated to synthesize useful quantities of D-arabinitol, riboflavin, xylitol, and pyruvic acid under thiamine limitation. Debaryomyces hansenii efficiently produces xylitol from D-xylose in wood hydrolysates, generating high xylitol:ethanol ratios. This capability is of potential importance in biomass conversion.

Exo-Enzymes

D. hansenii synthesizes several exo-enzymes including β-glucosidases, esterases, and inulinases, an enzyme system of increasing industrial importance.

Superoxide Dismutase and Antioxidant Enzymes

Debaryomyces hansenii BCS004 strain is a non-pathogenic, polyamine and superoxide dismutase secreting marine yeast. Antioxidant enzymes including superoxide dismutase and catalase activities are induced in leukocytes stimulated with D. hansenii β-glucans.

Mycocins (Killer Toxins)

Debaryomyces hansenii is an osmo-, halo-, and xerotolerant yeast that produces toxins, including mycocins, to destroy competitive yeast species. D. hansenii produces killer toxins active against various yeast species, which may be of value in maintaining aseptic conditions in industrial fermentations and for potential control of yeast infections.

Biomass Protein and Lipid Content

A marine strain of D. hansenii (Mo40) has been shown to produce a biomass containing 45% proteins and 20% lipids, making it an attractive candidate for use as a protein- and lipid-rich feed additive.

4. Mechanisms of Action

Immunomodulation via Pattern Recognition

Yeast contains a wide range of microbe-associated molecular patterns (MAMPs) — including α-glucan, β-glucan, α-mannan, and nucleic acids — which act on host pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and C-type lectin receptors (CLRs), activating cells of the immune system. These molecules can modulate the immune response, inducing both local effects in the intestine (strengthening the intestinal barrier and increasing resistance to infectious pathogens) and systemic effects, by regulating pro- and anti-inflammatory cytokines, effector molecules, and coordinating antigen-presenting cells.

Specifically for D. hansenii-derived β-glucans, in vitro data shows that β-glucans significantly increased immune cell parameters, such as phagocytic ability, reactive oxygen species production (respiratory burst), peroxidase activity, and nitric oxide production in leukocytes. Antioxidant enzymes revealed an increase in superoxide dismutase and catalase activities. β-glucans activated dectin-1 mRNA gene expression in leukocytes, and TLR4 gene expression was also upregulated. In conclusion, β-glucans were able to modulate the immune system by promoting cell viability, phagocytic activity, antioxidant immune response, and immune-related gene expression in leukocytes.

Gut Barrier and Microbiota Modulation

Probiotic properties, including immunostimulatory effects, gut microbiota modulation, enhanced cell proliferation and differentiation, and digestive function improvements have been related to the oral delivery of D. hansenii. Its functional compounds, such as cell wall components and polyamines, have been identified and implicated in its immunomodulatory activity.

Research has found that D. hansenii improves intestinal function and immunity while modulating gut microbiota, effects that may be associated with its positive impacts on fish growth and performance.

Halotolerance Mechanisms

Debaryomyces hansenii is usually found in salty environments such as the sea and salted food. It is capable of accumulating sodium without being intoxicated even when potassium is present at low concentration in the environment. Sodium improves growth and protects D. hansenii in the presence of additional stress factors such as high temperature and extreme pH.

Expression of genes related to oxidative stress is induced by exposure to NaCl and KCl, and, vice versa, transcription of some genes related to osmotic/salt stress responses is regulated by hydrogen peroxide (H₂O₂).

Crohn's Disease-Related Pathological Mechanism

Mechanistically, D. hansenii impaired mucosal healing through the myeloid cell-specific type 1 interferon–CCL5 axis. Additional experiments have suggested that type 1 interferons are important to stimulate CCL5 expression, which causes D. hansenii-induced disease pathology. This mechanism is specifically relevant in the context of inflamed and injured intestinal tissue, as discussed in the safety section below.

5. Scientific Evidence by Area of Use

5a. Aquaculture: Growth Performance and Gut Health

Debaryomyces hansenii is a yeast species that can be used as a probiotic in aquaculture due to its capacity to: (i) promote cell proliferation and differentiation, (ii) have immunostimulatory effects, (iii) modulate gut microbiota, and/or (iv) enhance digestive function.

A study exploring the effects of two supplementation levels of Debaryomyces hansenii (1.1% and 2.2%) as a probiotic in a reference low fish meal-based diet on skin mucosal tissue in gilthead sea bream (Sparus aurata) included evaluation of fish performance along with a holistic study of the skin mucosa involving transcriptomics and evaluation of secreted mucus. Results showed that after 70 days of diet administration, fish fed the diet supplemented with D. hansenii at 1.1% presented increased somatic growth and a better feed conversion ratio compared to fish fed the control diet. In contrast, fish fed the diet including 2.2% of the probiotic presented intermediate values.

Evidence strength: This is in vivo animal data (fish models) only. These studies are well-controlled but cannot be directly extrapolated to human physiology or health outcomes.

5b. Aquaculture: Immunostimulation in Marine Fish

One study investigated the marine yeast D. hansenii BCS004 as a probiotic and evaluated its antimicrobial properties and dietary immunostimulant effect on gilthead sea bream specimens when administered at 10⁶ colony-forming unit/g or 1.1% for 4 weeks. This yeast strain showed potential probiotic properties, including stability in gastrointestinal survival (pH, bile conditions) and attachment to intestinal cells. The strain had antimicrobial activity against important marine pathogens. Interestingly, this yeast has a high amount of n−3 polyunsaturated fatty acids. The in vivo immunological assay revealed that dietary supplementation significantly increased phagocytosis capacity, peroxidase and respiratory burst activities in leucocytes.

Evidence strength: Single animal study; demonstrates immunostimulatory potential in a non-mammalian model. No human clinical data available.

5c. Atlantic Salmon: Stress Modulation (Hydrolyzed Preparations)

A study described the effects of two hydrolyzed Debaryomyces hansenii yeast-based products (LAN4 and LAN6) on physiological and immune responses of Atlantic salmon (Salmo salar) parr exposed to short hypoxia stress. A commercial-like diet and two experimental diets (each supplemented with 0.1% of either LAN4 or LAN6) were fed to fish for 8 weeks. At the end of the feeding experiment, fish were exposed to 1-minute hypoxia. Results showed that plasma cortisol reached a peak at 1 hour post-stress in the control and LAN6 groups, whereas no significant increase in cortisol levels was detected in the LAN4 group. Moreover, the LAN6 group enhanced IL-10 responses to hypoxia compared to the control and LAN4 group.

Hypoxia stress increased TNFα in all groups, indicating that fish may compensate for the short-term stress response by modulating innate immune molecules. The apparent suppression of hypoxia responses in the LAN4 group coincided with the detection of differences in goblet cells size and Muc-like proteins production, and upregulation of pathways related to oxygen transport, hemoglobin complex, and glutathione transferase activity.

Evidence strength: In vivo animal study; provides mechanistic insights but cannot be translated to humans directly.

5d. Skin and Mucus Barrier (Marine Fish)

D. hansenii has been reported to enhance larval survival and development in several marine fish species, whereas in juveniles, it is reputed for promoting the immune system. Increased modulation and exudation of innate immune components from skin cells into the mucus has been reported in relation to the skin mucosal defensive capacity in bacteria co-culture in vitro trials.

Evidence strength: Preliminary; consists of in vitro and animal data. No comparable human skin or mucosal studies are available.

5e. β-Glucan Immunostimulation in Ruminants (In Vitro)

A study attempted to describe the immunostimulatory effects of the β-glucan content of D. hansenii through in vitro assays using goat peripheral blood leukocytes at 24 hours of stimulation. The structural characterization of yeast glucans by proton nuclear magnetic resonance indicated structures containing (1-6)-branched (1-3)-β-D-glucan. In vitro assays using peripheral blood leukocytes stimulated with β-glucans derived from three D. hansenii strains and zymosan revealed that β-glucans significantly increased cell immune parameters, such as phagocytic ability, reactive oxygen species production (respiratory burst), peroxidase activity, and nitric oxide production.

Evidence strength: In vitro study with non-human cells. Useful for mechanistic understanding; cannot be directly applied to human clinical outcomes.

5f. Crohn's Disease Association (Human Translational Research)

Alterations of the mycobiota composition associated with Crohn's disease (CD) are challenging to link to defining elements of pathophysiology, such as poor injury repair. Using culture-dependent and -independent methods, researchers discovered that Debaryomyces hansenii preferentially localized to and was abundant within incompletely healed intestinal wounds of mice and inflamed mucosal tissues of CD human subjects.

The researchers cultured biopsied intestinal tissue from patients with and without Crohn's disease, finding that D. hansenii was detected in most CD samples compared to only 10 percent of healthy samples. In an unrelated cohort of patients, researchers sequenced genomic DNA biopsied from various intestinal regions of Crohn's patients. They found that Debaryomyces was significantly enriched in inflamed regions of the intestines compared to non-inflamed regions sampled from the same patient.

D. hansenii cultures from injured mice and inflamed CD tissues impaired colonic healing when introduced into injured conventionally raised or gnotobiotic mice. D. hansenii was reisolated from injured areas of these mice, fulfilling Koch's postulates.

Evidence strength: This is a significant translational human/animal research study published in Science (2021). It provides strong evidence that D. hansenii may play a pathological role in Crohn's disease. These findings are of direct relevance to anyone considering using this organism as a dietary supplement.

5g. Fermented Food Safety and Sensory Outcomes (Human-Relevant)

Sausages inoculated with D. hansenii strains Y61 and Y67 exhibited decreases in lipid oxidation of 40.70% and 36.04%, respectively, and reductions in Enterobacteriaceae counts of 50% and 100%, respectively. The inoculating yeasts increased the lightness and redness of fermented sausages. The D. hansenii-inoculated sausages had higher levels of free amino acids and fatty acids, which improved the digestibility, sensory value, and safety of these sausages.

Evidence strength: Food science studies; demonstrate applied food safety and sensory benefits of D. hansenii as a starter culture but do not constitute human clinical probiotic evidence.

5h. Xylitol Production (Biotechnological)

Debaryomyces hansenii efficiently produces xylitol from D-xylose in wood hydrolysates, generating high xylitol:ethanol ratios. Some strains of D. hansenii are able to convert xylose to xylitol, an anti-caries sweetener. This is a biotechnological application rather than a direct probiotic use.

6. Body Systems and Health Areas of Association

• Gastrointestinal / Intestinal Immune System (GALT): Available literature on D. hansenii primarily addresses its effects on gut-associated lymphoid tissue (GALT). Research has found that D. hansenii improves intestinal function and immunity, meanwhile modulating gut microbiota.
• Innate Immune System: Immunostimulatory effects, gut microbiota modulation, enhanced cell proliferation and differentiation, and digestive function improvements have been related to the oral delivery of D. hansenii. Its functional compounds, such as cell wall components and polyamines, have been identified and implicated in its immunomodulatory activity.
• Skin and Mucosal Barrier: Little is known about the effects of D. hansenii dietary supplementation on mucosal-associated lymphoid tissues beyond the gut, and especially the effects on the skin. The 2023 study in gilthead sea bream began to address this gap in the fish model.
• Intestinal Wound Healing / Inflammatory Bowel: Mechanistically, D. hansenii impaired mucosal healing through the myeloid cell-specific type 1 interferon–CCL5 axis. This has led to identification of a fungus that inhabits inflamed Crohn's disease tissue and can lead to dysregulated mucosal healing.
• Metabolic / Nutritional: A marine strain of D. hansenii can produce a biomass containing 45% proteins and 20% lipids, and is also able to degrade phytic acid by a cell-bound phytase activity.
• Stress Response (Cortisol/Immune Axis): Hydrolyzed preparations have been shown to modulate cortisol responses and anti-inflammatory cytokine (IL-10) release under acute physiological stress in animal models.

7. Dosage Forms and Reported Dosages

No established human clinical dosage exists for D. hansenii as a dietary supplement, as no controlled human clinical trials have evaluated efficacy or dose-response in humans. The following dosages are taken directly from published animal and food science studies:

• Two supplementation levels — 1.1% and 2.2% of the diet — have been studied as probiotic doses in gilthead sea bream fed a low fish meal-based diet, with assessments of skin mucosal tissue responses.
• One aquaculture study administered D. hansenii BCS004 at 10⁶ colony-forming unit/g (equivalent to approximately 1.1% of the diet) for 4 weeks to evaluate immunostimulant effects in gilthead sea bream.
• Three experimental diets used doses of 0.5%, 1.0%, and 1.5% (corresponding to 10¹⁴, 10¹⁵, and 10¹⁶ CFU per gram of diet, respectively) of live yeast to evaluate growth and immune effects in tropical gar juveniles.
• For hydrolyzed D. hansenii yeast-based products (LAN4 and LAN6), experimental diets supplemented with 0.1% of either component were fed to Atlantic salmon parr for 8 weeks.

No human pharmacopeial or regulatory body has established a recommended dose for D. hansenii as a human dietary supplement.

8. Safety Considerations and Interactions

EFSA Qualified Presumption of Safety (QPS) Status

D. hansenii is included in the EFSA QPS (Qualified Presumption of Safety) list, which indicates that it is considered appropriate for food and feed-related applications at the species level. Studies reviewed by EFSA on D. hansenii through 2025 did not add any new information that would change the current QPS status of this species.

Virulence Characteristics

A 2023 study that analysed the virulence factors of a collection of 60 strains of D. hansenii concluded that most strains displayed no virulence trait or only presented the capability to produce biofilm.

One EFSA-reviewed study investigated factors potentially related to virulence in a collection of clinical and food/environmental isolated strains of D. hansenii. All tested D. hansenii strains were positive for sporadic virulence-related properties, but there were no statistically significant differences between the clinical and the food/environmental isolates. It is uncertain whether these strains can cause disease.

Crohn's Disease: A Specific Risk Signal

Research supports that D. hansenii is safe in healthy individuals, but may be problematic in Crohn's patients. Disease-associated defects can permit colonization of the epithelia with fungi typically excluded from the mucosa, including Debaryomyces hansenii, that has been shown to exacerbate inflammation or inhibit tissue healing.

The team found that levels of the yeast Debaryomyces hansenii are higher in Crohn's disease patients, particularly abundant within chronically inflamed regions of the colon and small intestine, indicative of unhealed intestinal wounds. It will be important to follow patients with D. hansenii infections over time to determine the clinical importance with respect to disease severity, progression, and response to Crohn's treatments.

Opportunistic Infection in Immunocompromised Patients

Debaryomyces hansenii accounts for up to 2% of invasive candidiasis cases.

The infection caused by D. hansenii may result in fungemia, a bloodstream infection involving the presence of fungi within the bloodstream. This condition has been observed mainly in patients with leukemia and lymphoma. D. hansenii has been linked to cases of endocarditis, an infection impacting the heart valves or inner lining of the heart chambers. Patients with congenital heart defects, prosthetic heart valves, or a history of intravenous drug use have been reported to develop endocarditis caused by this pathogen. Another manifestation includes peritonitis, characterized by infection of the abdominal cavity's lining. It has been noted in individuals undergoing chronic ambulatory peritoneal dialysis.

Antifungal Resistance Signals

One study analyzed the frequency and antifungal susceptibility of Candida and non-albicans species in diabetic foot infections; 9.5% of positive fungal cultures from 200 patients corresponded to D. hansenii. Resistance was noted in some isolates: two samples presented resistance to amphotericin, one to caspofungin, one to fluconazole, nine to flucytosine, one to itraconazole, six to micafungin, and five to voriconazole.

Strain Specificity and Variability

Depending on multiple factors, D. hansenii may affect diverse physicochemical characteristics in different matrices. There is general agreement about the significant generation of volatile and aromatic compounds caused by the metabolic activities of this yeast. However, it is not possible to predict what the results would be after the inoculation of a product with a selected D. hansenii strain without a pivotal previous study. This principle of strain-specificity applies equally to any claimed probiotic benefits: effects documented for one strain cannot be presumed to generalize to all isolates of the species.

Summary of Evidence Gaps

D. hansenii is not Saccharomyces boulardii and is not a medicine. Human clinical evidence is limited, strain effects vary, and safety depends on context, especially for people with weakened immunity or active inflammatory bowel disease. The totality of the published peer-reviewed literature indicates that D. hansenii has been studied primarily as a food culture microorganism and as a probiotic additive in aquaculture species. As of 2025/2026, no randomized controlled trials in humans investigating its use as a human dietary supplement have been identified in the scientific literature.

References

• Firmino JP et al. (2023). "Dietary Debaryomyces hansenii promotes skin and skin mucus defensive capacities in a marine fish model." Frontiers in Immunology / PMC.
• Firmino JP et al. (2023). "Debaryomyces hansenii supplementation in low fish meal diets promotes growth, modulates microbiota and enhances intestinal condition in juvenile marine fish." Journal of Animal Science and Biotechnology.
• Reyes-Becerril M et al. (2021). "Probiotic properties of Debaryomyces hansenii BCS004 and their immunostimulatory effect in supplemented diets for gilthead seabream (Sparus aurata)." Aquaculture Research.
• García-Mena J et al. (2020). "Probiotic and nutritional effects of Debaryomyces hansenii on animals." Applied Microbiology and Biotechnology.
• Morales-Lange B et al. (2022). "Dietary Inclusion of Hydrolyzed Debaryomyces hansenii Yeasts Modulates Physiological Responses in Plasma and Immune Organs of Atlantic Salmon (Salmo salar) Parr Exposed to Acute Hypoxia Stress." PMC / Frontiers in Physiology.
• Jain U et al. (2021). "Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice." PubMed / Science.
• Jain U et al. (2021). "Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice." Science.
• Cleveland Clinic Newsroom (2021). "Cleveland Clinic Researchers Discover Microbial Infection That Impairs Healing in Crohn's Disease."
• Prista C et al. (2005). "Mechanisms underlying the halotolerant way of Debaryomyces hansenii." FEMS Yeast Research.
• Michán C et al. (2013). "Salt and oxidative stress tolerance in Debaryomyces hansenii and Debaryomyces fabryi." FEMS Yeast Research.
• Desnos-Ollivier M et al. (2009). "Differentiation of Debaryomyces hansenii and Candida famata by rRNA gene intergenic spacer fingerprinting…" FEMS Yeast Research.
• ScienceDirect Topics. "Debaryomyces hansenii — an overview." (Biochemistry, Genetics and Molecular Biology).
• ScienceDirect Topics. "Debaryomyces hansenii — an overview." (Immunology and Microbiology).
• ScienceDirect Topics. "Debaryomyces hansenii — an overview." (Agricultural and Biological Sciences).
• Flores M et al. (2021). "Debaryomyces hansenii Is a Real Tool to Improve a Diversity of Characteristics in Sausages and Dry-Meat Products." Microorganisms (MDPI).
• Xiao Q et al. (2024). "Debaryomyces hansenii Strains from Traditional Chinese Dry-Cured Ham as Good Aroma Enhancers in Fermented Sausage." Fermentation (MDPI).
• EFSA (2024). "Update of the list of QPS recommended microbiological agents intentionally added to food or feed as notified to EFSA 20." EFSA Journal.
• EFSA (2025). "Update of the list of QPS recommended microbiological agents intentionally added to food or feed as notified to EFSA 22." PMC / EFSA Journal.
• EFSA (2022). "Update of the list of QPS recommended microbiological agents intentionally added to food or feed as notified to EFSA 16." PMC / EFSA Journal.
• EFSA (2021). "Update of the list of QPS biological agents intentionally added to food or feed as notified to EFSA 15." PMC / EFSA Journal.
• EFSA (2018). "Update of the list of QPS biological agents intentionally added to food or feed as notified to EFSA 8." EFSA Journal.
• Binati RL et al. (2022). "Bioprocesses with Reduced Ecological Footprint by Marine Debaryomyces hansenii Strain for Potential Applications in Circular Economy." PMC.
• Tarrío-Saavedra J et al. (2022). "DebaryOmics: an integrative –omics study to understand the halophilic behaviour of Debaryomyces hansenii." PMC.
• Neves L et al. (2014). "Characterization of New Polyol/H⁺ Symporters in Debaryomyces hansenii." PMC.
• World Register of Marine Species (WoRMS). "Debaryomyces hansenii (Zopf) Lodder & Kreger-van Rij, 1984."
• Wikipedia. "Debaryomyces hansenii."
• NCBI Taxonomy Browser. "Debaryomyces hansenii" (Taxonomy ID: 4959).
• Alvarez-González CA et al. (2021). "Dietary live yeast (Debaryomyces hansenii) provides no advantages in tropical gar, Atractosteus tropicus, juvenile aquaculture." Acta Ichthyologica et Piscatoria (Pensoft).
• Ren Y et al. (2025). "Soy Protein Isolate Supplementation Favorably Regulates the Fermentation Characteristics of Debaryomyces hansenii and Flavor Profile in a Sausage Model." PMC.
• Ramos J et al. (2009). "Debaryomyces hansenii: An Osmotolerant and Halotolerant Yeast." Springer Nature Link.
• Science.gov Topic Pages. "Debaryomyces hansenii Candida."